Articles tagged with: DEPO
Depomed Receives Certification Notice (NASDAQ:DEPO)
Depomed, Inc (NASDAQ:DEPO) announced that they have received a Paragraph IV certification notice from Lupin Limited advising Depomed of the filing of an Abbreviated New Drug Application (ANDA) with the Food and Drug Administration for …
Depomed Q3 Financial Results (NASDAQ:DEPO)
Depomed, Inc (NASDAQ:DEPO) today reported financial results for the third quarter that ended on September 30, 2009.
Depomed’s New Shingle Drug (NASDAQ:DEPO)
On the very first day of the week, Depomed Inc has come out with good news that their new shingles pain drug has met the study goal. Depomed has announced that they have achieved success …
